LSU may be about to sell its stake in TransGenRx, a biopharmaceutical manufacturing company founded in 2003 that essentially uses genetically altered eggs to produce proteins for human medicines. The …
Already an INSIDER? Sign in.
We are glad you enjoy reading Business Report.
Continue reading this story and get ACCESS to all our content from any device with a subscription now.
- Get access to more than a decade of story archives.
- Get access to our searchable data center of TOP LISTS.
- Get exclusive content only available to INSIDERS.